Rapamycin may inhibit murine S180 sarcoma growth by regulating the pathways associated with autophagy and cancer stem cells | |
Shi, Hubo; Zhang, Lulu; Zhang, Chengke; Hao, Yingtao; Zhao, Xiaogang | |
刊名 | JOURNAL OF CANCER RESEARCH AND THERAPEUTICS |
2019 | |
卷号 | 15期号:2页码:398-403 |
关键词 | Autophagy cancer stem cell rapamycin |
DOI | 10.4103/jcrt.JCRT_639_18 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4530200 |
专题 | 山东大学 |
作者单位 | 1.Shandong Univ, Hosp 2, Dept Thorac Surg, Jinan 250033, Shandong, Peoples R China. 2.[Zhang, |
推荐引用方式 GB/T 7714 | Shi, Hubo,Zhang, Lulu,Zhang, Chengke,et al. Rapamycin may inhibit murine S180 sarcoma growth by regulating the pathways associated with autophagy and cancer stem cells[J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS,2019,15(2):398-403. |
APA | Shi, Hubo,Zhang, Lulu,Zhang, Chengke,Hao, Yingtao,&Zhao, Xiaogang.(2019).Rapamycin may inhibit murine S180 sarcoma growth by regulating the pathways associated with autophagy and cancer stem cells.JOURNAL OF CANCER RESEARCH AND THERAPEUTICS,15(2),398-403. |
MLA | Shi, Hubo,et al."Rapamycin may inhibit murine S180 sarcoma growth by regulating the pathways associated with autophagy and cancer stem cells".JOURNAL OF CANCER RESEARCH AND THERAPEUTICS 15.2(2019):398-403. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论